Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

3.23
Delayed Data
As of Aug 28
 +0.15 / +4.87%
Today’s Change
1.76
Today|||52-Week Range
4.67
-0.62%
Year-to-Date

Today’s Trading

Previous close3.08
Today’s open3.09
Day’s range3.05 - 3.23
Volume1,850,308
Average volume (3 months)2,359,531
Market cap$510.8M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+23.33%
Earnings growth (this year)+100.00%
Earnings growth (next 5 years)--
Revenue growth (last year)-10.13%
P/E ratioNM
Price/Sales432.79
Price/Book3.89

Competitors

 Today’s
change
Today’s
% change
--Quidel Corp+0.26+1.46%
ALRPRBAlere Inc+10.35+3.06%
TRIBTrinity Biotech PLC-0.44-2.77%
BDSIBioDelivery Sciences...+0.23+3.46%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)$0.17
Annual revenue (last year)$1.2M
Annual profit (last year)-$35.7M
Net profit margin-3,093.67%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers